Jul 25, 2014 at 21:22 | Source: CNBC-TV18
The pressure is building up on the Indian drug regulator to clampdown on the fake drugs that are inundating the Indian market. A desperate CDSCO has decided to restart an old scheme -- reward to any whistleblower who is instrumental in the seizure of counterfeit drugs and cosmetics.
Jul 25, 2014 at 15:37 | Source: Moneycontrol.com
Parabolic Drugs Ltd has informed BSE that Mr. Balbir Singh Bhasin, Nominee Director of State Bank of India (SBI) has resigned from the Board of Directors of the Company w.e.f. July 02, 2014.
Jul 24, 2014 at 19:13 | Source: PTI
The licensing agreement extends Ranbaxy's current relationship with Cipher, under which it is marketing isotretinoin capsules in the US under the brand 'Absorica', Ranbaxy Laboratories said in a statement.
Jul 24, 2014 at 12:57 | Source: Moneycontrol.com
After inspecting the companys active pharmaceutical ingredients (APIs) manufacturing unit at Raltam, US Food and Drug Administration (US FDA) has raised some concerns in Form 483. Hence the drug manufacturer will suspend shipments to the US markets till the issue is addressed.
Jul 23, 2014 at 21:19 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals board meeting will be held on July 30, 2014, to transact the items of business thereat to review the performance of the Company and Consider, approve and take on record the unaudited financial results for the quarter ended June 30, 2014.
Jul 23, 2014 at 16:59 | Source: Moneycontrol.com
Venmax Drugs and Pharmaceuticals has board meeting will be held on July 28, 2014, to consider the following : 1. To consider and take note of the Unaudited financial results for the quarter ended June 30, 2014. 2. To review the working of the Company. 3. To decide the date of AGM for the Year 2013-14.
Jul 23, 2014 at 16:20 | Source: PTI
The capsule is an immuno-suppressant used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.
Jul 23, 2014 at 11:35 | Source: Moneycontrol.com
Strides Arcolab today announced that it has received approval from the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg.
Jul 23, 2014 at 10:42 | Source: Moneycontrol.com
With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to come under pressure, says an ICRA report.
Jul 22, 2014 at 18:21 | Source: Reuters
GSK is looking to divest the mature products in a bid to improve its growth profile and wants to dispose of off-patent drugs marketed in North America and western Europe with annual sales of around 1 billion pounds (USD 1.7 billion).